The Ensign Group, Inc. (ENSG)
USD 128.17
(-0.01%)
USD 128.17
(-0.01%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.68 Billion USD | 21.65% |
| 2022 | 2.2 Billion USD | 20.47% |
| 2021 | 1.82 Billion USD | 5.88% |
| 2020 | 1.72 Billion USD | 1.27% |
| 2019 | 1.7 Billion USD | 194.29% |
| 2018 | 579.61 Million USD | -3.78% |
| 2017 | 602.37 Million USD | 11.44% |
| 2016 | 540.53 Million USD | 68.51% |
| 2015 | 320.77 Million USD | 35.86% |
| 2014 | 236.11 Million USD | -41.42% |
| 2013 | 403.05 Million USD | 11.04% |
| 2012 | 362.97 Million USD | 13.84% |
| 2011 | 318.85 Million USD | 26.69% |
| 2010 | 251.68 Million USD | 23.5% |
| 2009 | 203.78 Million USD | 44.65% |
| 2008 | 140.88 Million USD | 2.3% |
| 2007 | 137.71 Million USD | -1.2% |
| 2006 | 139.38 Million USD | 60.66% |
| 2005 | 86.75 Million USD | 0.0% |
| 2003 | 55.19 Million USD | 78.9% |
| 2002 | 30.85 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.72 Billion USD | 1.67% |
| 2024 Q3 | 2.87 Billion USD | 3.75% |
| 2024 Q2 | 2.77 Billion USD | 1.81% |
| 2023 Q4 | 2.68 Billion USD | 2.43% |
| 2023 FY | 2.68 Billion USD | 21.65% |
| 2023 Q1 | 2.54 Billion USD | 15.4% |
| 2023 Q2 | 2.55 Billion USD | 0.65% |
| 2023 Q3 | 2.61 Billion USD | 2.25% |
| 2022 Q1 | 1.97 Billion USD | 7.85% |
| 2022 Q3 | 2.08 Billion USD | 3.97% |
| 2022 FY | 2.2 Billion USD | 20.47% |
| 2022 Q2 | 2 Billion USD | 1.59% |
| 2022 Q4 | 2.2 Billion USD | 5.74% |
| 2021 Q1 | 1.63 Billion USD | -5.24% |
| 2021 FY | 1.82 Billion USD | 5.88% |
| 2021 Q2 | 1.71 Billion USD | 5.07% |
| 2021 Q3 | 1.83 Billion USD | 6.64% |
| 2021 Q4 | 1.82 Billion USD | -0.28% |
| 2020 Q1 | 1.71 Billion USD | 0.32% |
| 2020 Q4 | 1.72 Billion USD | 1.64% |
| 2020 Q2 | 1.77 Billion USD | 3.46% |
| 2020 Q3 | 1.69 Billion USD | -4.01% |
| 2020 FY | 1.72 Billion USD | 1.27% |
| 2019 Q2 | 1.64 Billion USD | 4.5% |
| 2019 Q3 | 1.65 Billion USD | 0.82% |
| 2019 Q4 | 1.7 Billion USD | 2.9% |
| 2019 FY | 1.7 Billion USD | 194.29% |
| 2019 Q1 | 1.57 Billion USD | 171.45% |
| 2018 Q3 | 571.19 Million USD | -0.76% |
| 2018 Q4 | 579.61 Million USD | 1.47% |
| 2018 Q2 | 575.56 Million USD | 1.55% |
| 2018 FY | 579.61 Million USD | -3.78% |
| 2018 Q1 | 566.76 Million USD | -5.91% |
| 2017 Q1 | 526.15 Million USD | -2.66% |
| 2017 Q4 | 602.37 Million USD | 3.2% |
| 2017 Q3 | 583.68 Million USD | 4.0% |
| 2017 Q2 | 561.22 Million USD | 6.66% |
| 2017 FY | 602.37 Million USD | 11.44% |
| 2016 Q3 | 415.79 Million USD | -0.04% |
| 2016 FY | 540.53 Million USD | 68.51% |
| 2016 Q4 | 540.53 Million USD | 30.0% |
| 2016 Q2 | 415.98 Million USD | 14.44% |
| 2016 Q1 | 363.48 Million USD | 13.31% |
| 2015 Q4 | 320.77 Million USD | 18.23% |
| 2015 Q3 | 271.3 Million USD | 16.93% |
| 2015 Q2 | 232.02 Million USD | 21.1% |
| 2015 Q1 | 191.59 Million USD | -18.85% |
| 2015 FY | 320.77 Million USD | 35.86% |
| 2014 FY | 236.11 Million USD | -41.42% |
| 2014 Q2 | 145.52 Million USD | -63.59% |
| 2014 Q3 | 158.56 Million USD | 8.96% |
| 2014 Q4 | 236.11 Million USD | 48.91% |
| 2014 Q1 | 399.67 Million USD | -0.84% |
| 2013 Q1 | 394.58 Million USD | 8.71% |
| 2013 Q4 | 403.05 Million USD | 1.66% |
| 2013 Q2 | 393.34 Million USD | -0.32% |
| 2013 Q3 | 396.47 Million USD | 0.8% |
| 2013 FY | 403.05 Million USD | 11.04% |
| 2012 Q3 | 337.37 Million USD | 2.09% |
| 2012 Q1 | 321.17 Million USD | 0.73% |
| 2012 Q2 | 330.47 Million USD | 2.89% |
| 2012 Q4 | 362.97 Million USD | 7.59% |
| 2012 FY | 362.97 Million USD | 13.84% |
| 2011 Q1 | 259.06 Million USD | 2.93% |
| 2011 FY | 318.85 Million USD | 26.69% |
| 2011 Q4 | 318.85 Million USD | 6.1% |
| 2011 Q3 | 300.51 Million USD | 18.59% |
| 2011 Q2 | 253.4 Million USD | -2.18% |
| 2010 Q2 | 204.19 Million USD | -0.72% |
| 2010 Q4 | 251.68 Million USD | 20.58% |
| 2010 Q3 | 208.72 Million USD | 2.22% |
| 2010 FY | 251.68 Million USD | 23.5% |
| 2010 Q1 | 205.66 Million USD | 0.92% |
| 2009 Q4 | 203.78 Million USD | 42.9% |
| 2009 Q3 | 142.61 Million USD | -0.42% |
| 2009 Q2 | 143.21 Million USD | -0.99% |
| 2009 FY | 203.78 Million USD | 44.65% |
| 2009 Q1 | 144.64 Million USD | 2.67% |
| 2008 Q2 | 133.98 Million USD | -0.34% |
| 2008 FY | 140.88 Million USD | 2.3% |
| 2008 Q4 | 140.88 Million USD | 5.17% |
| 2008 Q3 | 133.95 Million USD | -0.02% |
| 2008 Q1 | 134.43 Million USD | -2.38% |
| 2007 Q1 | 139.69 Million USD | 0.22% |
| 2007 Q3 | 138.97 Million USD | 2.42% |
| 2007 FY | 137.71 Million USD | -1.2% |
| 2007 Q4 | 137.71 Million USD | -0.91% |
| 2007 Q2 | 135.69 Million USD | -2.86% |
| 2006 FY | 139.38 Million USD | 60.66% |
| 2006 Q4 | 139.38 Million USD | 0.0% |
| 2005 Q4 | 86.75 Million USD | 0.0% |
| 2005 FY | 86.75 Million USD | 0.0% |
| 2003 FY | 55.19 Million USD | 78.9% |
| 2002 FY | 30.85 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | -8.459% |
| Addus HomeCare Corporation | 317.73 Million USD | -743.549% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -1968.713% |
| Amedisys, Inc. | 940.38 Million USD | -185.013% |
| American Oncology Network, Inc. | 368.72 Million USD | -626.888% |
| Astrana Health, Inc. | 522.59 Million USD | -412.87% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | -51.889% |
| IMAC Holdings, Inc. | 1.89 Million USD | -141204.937% |
| biote Corp. | 191.84 Million USD | -1297.107% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -3609.55% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | -1201.56% |
| COMPASS Pathways plc | 50.24 Million USD | -5234.522% |
| DocGo Inc. | 185.28 Million USD | -1346.572% |
| Healthcare Services Group, Inc. | 346.56 Million USD | -673.366% |
| InnovAge Holding Corp. | 247.85 Million USD | -981.376% |
| Assure Holdings Corp. | 22.84 Million USD | -11630.159% |
| The Joint Corp. | 62.37 Million USD | -4196.678% |
| LifeStance Health Group, Inc. | 804.27 Million USD | -233.246% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -70225.638% |
| ModivCare Inc. | 1.61 Billion USD | -66.362% |
| NewGenIvf Group Limited | 1.24 Million USD | -215797.248% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -24124.79% |
| Option Care Health, Inc. | 1.9 Billion USD | -40.57% |
| P3 Health Partners Inc. | 427.3 Million USD | -527.239% |
| P3 Health Partners Inc. | 427.3 Million USD | -527.239% |
| The Pennant Group, Inc. | 394.17 Million USD | -579.956% |
| Surgery Partners, Inc. | 3.65 Billion USD | 26.714% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -294406.808% |
| Talkspace, Inc. | 23.57 Million USD | -11268.925% |
| Talkspace, Inc. | 23.57 Million USD | -11268.925% |
| The Oncology Institute, Inc. | 162.39 Million USD | -1550.455% |
| The Oncology Institute, Inc. | 162.39 Million USD | -1550.455% |